A panel of transferable fragments of human chromosome 11q

Cytogenetics and Cell Genetics

Volumn 79, Issue 1-2, 1997, Pages 53-59

  Robertson, G P ^a   Hufford, H ^a   Lugo, T G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; MICROSATELLITE DNA;

ANIMAL CELL; ARTICLE; CENTROMERE; CHROMOSOME 11Q; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMOSOMES, HUMAN, PAIR 11; DEMECOLCINE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; HYBRID CELLS; MELANOMA; MICE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031414702     PISSN: 03010171     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000134682     Document Type: Article

References (33)

1. BalYa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S, Croce CM: Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 56:268-272 (1996).
2. Barch MJ (ed): The ACT Cytogenetics Laboratory Manual, 2nd Ed, pp 180-181, 433-434 (Raven Press, New York 1991).
3. Bell GI, Karam JH, Rutter WJ: Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc natl Acad Sci, USA 78:5759-5763 (1981).
4. Davis M, Hitchcock A, Foulkes WD, Campbell IG: Refinement of two chromosome 11 regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741-744 (1996).
5. Ejima Y, Oshimura M, Sasaki MS: Generation of a panel of radiation-reduced hybrids containing human llq22-23 fragments bearing a HPRT selective marker: identification of hybrids carrying various subregions around the ataxia-telangiectasia locus. Somat Cell molec Genet 22:499-509 (1996).
6. Evans KL, van Heyningen V, Porteous DJ: Placement and refined mapping of established and new markers on human chromosome 1 Iq using a small panel of somatic cell hybrids. Eur J hum Genet 3:42-48 (1995).
7. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RCF, Steel CM, Porteous DJ, Smyth JF: Definition and refinement of a region of loss of heterozygosity at I Iq23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56:950-954(1996).
8. Gerhard DS, Lawrence E, Wu J, Chua H, Ma N, Bland S, Jones C: Isolation of 1001 new markers from human chromosome 11, excluding the region of 11 p 13 -15., p 15.5, and their sublocalization by a new series of radiation-reduced somatic cell hybrids. Genomics 13:1133-1142 (1992).
9. Gillett GT, McConville CM, Byrd PJ, Stankovic T, Taylor AM, Hunt DM, West LF, Fox MF, Povey S, Bcnham FJ: Irradiation hybrids for human chromosome 11: characterization and use for generating region-specific markers in 1 lq 14 —»q23. Genomics 15:332-341 (1993).
10. Goldberg EK, Robertson G, Glendening JM, Walker GJ, Hayward NK, Lugo TG, Fountain JW: Molecular and functional definition of an 1 lq region targeted in melanoma. Am J hum Genet 59(Suppl 4):A69 (1996).
11. Haber DA, Housman DE: Role of the WTI gene in Wilms' tumour, in Levine AJ (ed): Tumour Suppressor Genes, the Cell Cycle and Cancer, pp 105-117 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1992).
12. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RM, Williams AW, Steel CM, Bird CC, Stanbridge EJ, Evans GA: Loss of heterozygosity in cervical carcinoma: subchro-mosomal localization of a putative tumor-suppres-sor gene to chromosome I Iq22->q24. Proc natl Acad Sci, USA 91:6953-6957 (1994).
13. Healy E, Rehman I, Angus B, Rees JL: Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chrom Cancer 12:152-156 (1995).
14. Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC: A defined region of loss of heterozygosity at 1 lq23 in cutaneous malignant melanoma. Cancer Res 55:2494-2496 (1995).
15. James MR. Richard 3rd CW. Schott JJ. Yousry C, Clark K. Bell J, Terwilliger JD. Hazan J, Dubav C, Vignal A, Agrapart M, Imai T, Nakamura Y, Poly-meropoulos M, Weissenbach J, Cox DR. Lathrop GM: A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nature Genet 8:70-76(1994).
16. Jongmans W, Vcrhaegh GWCT, Jaspers NGJ, Oshimu-ra M, Stanbridge EJ, Lohman PHM, Zdzienicka MZ: Studies on phenotypic complementation of ataxia-telangiectasia cells by chromosome transfer. Am J hum Genet 56:438-443 (1995).
17. Keldysh PL, Dragani TA, Fleischman EW, Konstantinova LN, Perevoschikov AG, Pierotti MA, Della Porta G, Kopnin BP: Iq Deletions in human colorectal carcinomas: cylogcnctics and restriction fragment length polymorphism analysis. Genes Chrom Cancer 6:45-50 (1993).
18. Killarv AM, Fournier RE: Microcell fusion, in Vogt PK, Verma I (eds): Methods in Enzymology, Vol 254, pp 133-152 (Academic Press, San Diego 1995).
19. Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP: Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome II. Science 260:361-364 (1993).
20. Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M: Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinogen 2:12-21 (1989).
21. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nor-denskjold M: Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87 (1988).
22. Loh Jr WE, Scrable HJ, Livanos E, Arboleda MJ, Cav-enee WK, Oshimura M, Weissman BE: Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc natl Acad Sci, USA 89:1755-1759 (1992).
23. Lugo TG, Handelin B, Killarv AM, Housman DE, Fournier REK: Isolation of microcell hybrid clones containing retroviral insertions into specific human chromosomes. Mol cell Biol 7:2814-2820 (1987).
24. Misra BC, Srivatsan ES: Localization of HcLa cell tumor-suppressor gene to the long arm of chromosome 11. Am J hum Genet 45:565-577 (1989).
25. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, CaveneeWK, Croce CM: Definition and refinement of chromosome 11 regionsoflossofheterozy-gosity in breast cancer: identification of a new region at 1 lq23.3. Cancer Res 55:3003-3007 (1995).
26. Negrini M, Sabbioni S, Possati L, Rattan S, C'orallini A. Barbanti-Brodano G, Croce CM: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 54:1331-1336 (1994).
27. Rasio D, Negrini M, Croce CM: Genomic organization of the ATM locus involved in ataxia-telangiectasia. Cancer Res 55:6053-6057 (1995a).
28. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM: Loss of heterozygosity at chromosome 1 Iq in lung adenocarcinoma: identification of three independent regions. Cancer Res 55:3988-3991 (1995b).
29. Robertson G, Coleman A, Lugo TG: A malignant melanoma tumor suppressor on human chromosome 11. Cancer Res 56:4487-4492 (1996a).
30. Robertson GP, Coleman AB, LugoTG: Meehan isms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res 56:1635-1641 (1996b).
31. Rose EA, Glaser T, Jones C, Smith C, Lewis WH, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE: Complete physical map of the WAGR region of 11 pi3 localizes a candidate Wilms’ tumor gene. Cell 60:495-508 (1990).
32. Trask B, Pinkel D: Fluorescence in situ hybridization w’ith DNA probes, in Crissman HA. Darzynkie-wicz Z (eds): Methods in Cell Biology, Vol 33, pp 383-400 (Academic Press. New York 1990).
33. Trent JM, Stanbridge FJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB: Tumorigenicity in human melanoma lines controlled by introduction of human chromosome 6. Science 247:568-571 (1990).